Augmedix Price to Book Ratio 2019-2023 | AUGX
Historical price to book ratio values for Augmedix (AUGX) over the last 10 years. The current price to book ratio for Augmedix as of May 10, 2024 is 4.43.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
Augmedix Price/Book Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | Book Value per Share | Price to Book Ratio |
2024-05-10 | 2.23 | 4.64 | |
2023-12-31 | 5.85 | $0.48 | 12.20 |
2023-09-30 | 5.15 | $0.02 | 289.33 |
2023-06-30 | 4.81 | $0.10 | 49.18 |
2023-03-31 | 1.74 | $-0.08 | -20.49 |
2022-12-31 | 1.56 | $0.04 | 39.80 |
2022-09-30 | 1.45 | $0.17 | 8.42 |
2022-06-30 | 1.80 | $0.30 | 6.03 |
2022-03-31 | 2.94 | $0.49 | 6.05 |
2021-12-31 | 3.15 | $0.64 | 4.89 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $0.122B | $0.045B |
Augmedix Inc. is a provider of remote medical documentation and live clinical support. Augmedix Inc. is based in SAN FRANCISCO, Calif. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
GE HealthCare Technologies (GEHC) | United States | $37.763B | 20.73 |
Inspire Medical Systems (INSP) | United States | $5.181B | 0.00 |
Axonics (AXNX) | United States | $3.439B | 0.00 |
10x Genomics (TXG) | United States | $3.145B | 0.00 |
IRhythm Technologies (IRTC) | United States | $3.107B | 0.00 |
Azenta (AZTA) | United States | $2.928B | 159.12 |
Olink Holding AB (publ) (OLK) | Sweden | $2.910B | 0.00 |
Enovis (ENOV) | United States | $2.800B | 20.75 |
Hims & Hers Health (HIMS) | United States | $2.768B | 0.00 |
Privia Health (PRVA) | United States | $2.139B | 120.20 |
Schrodinger (SDGR) | United States | $1.673B | 0.00 |
Omnicell (OMCL) | United States | $1.389B | 48.02 |
Phreesia (PHR) | United States | $1.238B | 0.00 |
Standard BioTools (LAB) | United States | $0.699B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.652B | 0.00 |
Definitive Healthcare (DH) | United States | $0.610B | 0.00 |
Talkspace (TALK) | United States | $0.483B | 0.00 |
Clover Health Investments (CLOV) | United States | $0.428B | 0.00 |
Health Catalyst (HCAT) | United States | $0.394B | 0.00 |
Pulmonx (LUNG) | United States | $0.340B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.314B | 0.00 |
P3 Health Partners (PIII) | United States | $0.231B | 0.00 |
Butterfly Network (BFLY) | United States | $0.205B | 0.00 |
Outset Medical (OM) | United States | $0.169B | 0.00 |
American Well (AMWL) | United States | $0.152B | 0.00 |
TruBridge (TBRG) | United States | $0.123B | 5.26 |
MSP Recovery (LIFW) | United States | $0.120B | 0.00 |
111 (YI) | China | $0.095B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.073B | 0.00 |
Future Health ESG (FHLT) | United States | $0.071B | 0.00 |
SHL Telemedicine (SHLT) | Israel | $0.060B | 0.00 |
Zepp Health (ZEPP) | China | $0.054B | 0.00 |
HeartBeam (BEAT) | United States | $0.053B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.046B | 0.00 |
Movano (MOVE) | United States | $0.039B | 0.00 |
Akili (AKLI) | United States | $0.035B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.033B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
CareCloud (CCLD) | United States | $0.021B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.021B | 0.00 |
Cue Health (HLTH) | United States | $0.021B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
Biotricity (BTCY) | United States | $0.011B | 0.00 |
Syra Health (SYRA) | United States | $0.009B | 0.00 |
Transgenomic (PRPO) | United States | $0.008B | 0.00 |
Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
HeartSciences (HSCS) | United States | $0.006B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.005B | 0.00 |
Zhongchao (ZCMD) | China | $0.003B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.001B | 0.00 |
Centogene (CNTG) | Germany | $0.000B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |